Journal article · 2026

Development of pH-Resilient Boronic Acid ENPP1 Inhibitors for STING-Mediated Cancer Immunotherapy

Yaling Li, Meiling He, Jing-Dong Zhang, Ting Shi, Shan He, Ziqiang Chen, Chaowen Yang, Xiaomei Chen, Shuai Wang, You‐Cai Xiao, Fen‐Er Chen

Journal of Medicinal Chemistry, 69(20), 24096–24120 · Published 8 October 2026 · DOI 10.1021/acs.jmedchem.6c01649

View at the publisherCite this paper

In brief

“Development of pH-Resilient Boronic Acid ENPP1 Inhibitors for STING-Mediated Cancer Immunotherapy” is a 2026 journal article by Yaling Li and 10 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 1 citations as of 16 November 2026, which puts it in the top 9% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
2.98
References
51
Authors
11

Abstract

Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) hydrolyzes cGAMP within the tumor microenvironment (TME), suppressing stimulator of interferon genes (STING)-mediated antitumor immunity. Inspired by the phosphate-based inhibitor STF-1084, we developed a novel class of non-nucleotide ENPP1 inhibitors featuring a boronic acid zinc-binding group (ZBG), which led to the identification of the potent and pH-resilient compound 36. In vitro… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Li, Y., He, M., Zhang, J.-D., Shi, T., He, S., Chen, Z., Yang, C., Chen, X., Wang, S., Xiao, Y., & Chen, F. (2026). Development of pH-Resilient Boronic Acid ENPP1 Inhibitors for STING-Mediated Cancer Immunotherapy. Journal of Medicinal Chemistry, 69(20), 24096–24120. https://doi.org/10.1021/acs.jmedchem.6c01649

MLA 9

Li, Yaling, et al. “Development of pH-Resilient Boronic Acid ENPP1 Inhibitors for STING-Mediated Cancer Immunotherapy.” Journal of Medicinal Chemistry, vol. 69, no. 20, 2026, pp. 24096–24120. https://doi.org/10.1021/acs.jmedchem.6c01649.

Chicago

Li, Yaling, Meiling He, Jing-Dong Zhang, Ting Shi, Shan He, Ziqiang Chen, Chaowen Yang, et al. 2026. “Development of pH-Resilient Boronic Acid ENPP1 Inhibitors for STING-Mediated Cancer Immunotherapy.” Journal of Medicinal Chemistry 69 (20): 24096–24120. https://doi.org/10.1021/acs.jmedchem.6c01649.

Harvard

Li, Y. et al. (2026) ‘Development of pH-Resilient Boronic Acid ENPP1 Inhibitors for STING-Mediated Cancer Immunotherapy’, Journal of Medicinal Chemistry, 69(20), pp. 24096–24120. doi:10.1021/acs.jmedchem.6c01649.

IEEE

Y. Li et al., “Development of pH-Resilient Boronic Acid ENPP1 Inhibitors for STING-Mediated Cancer Immunotherapy,” Journal of Medicinal Chemistry, vol. 69, no. 20, pp. 24096–24120, 2026, doi: 10.1021/acs.jmedchem.6c01649.

BibTeX

@article{li2026development,
  title     = {{Development of pH-Resilient Boronic Acid ENPP1 Inhibitors for STING-Mediated Cancer Immunotherapy}},
  author    = {Li, Yaling and He, Meiling and Zhang, Jing-Dong and Shi, Ting and He, Shan and Chen, Ziqiang and Yang, Chaowen and Chen, Xiaomei and Wang, Shuai and Xiao, You‐Cai and Chen, Fen‐Er},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2026},
  volume    = {69},
  number    = {20},
  pages     = {24096--24120},
  doi       = {10.1021/acs.jmedchem.6c01649},
  url       = {https://doi.org/10.1021/acs.jmedchem.6c01649}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling

  • STING activation
  • cancer immunotherapy
  • tumor microenvironment
  • CT26 cells
  • antitumor immunity

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Li, Y., He, M., Zhang, J.-D., Shi, T., He, S., Chen, Z., Yang, C., Chen, X., Wang, S., Xiao, Y., & Chen, F. (2026). Development of pH-Resilient Boronic Acid ENPP1 Inhibitors for STING-Mediated Cancer Immunotherapy. Journal of Medicinal Chemistry, 69(20), 24096–24120. https://doi.org/10.1021/acs.jmedchem.6c01649

How many times has this paper been cited?

1 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Yaling Li, Meiling He, Jing-Dong Zhang, Ting Shi, Shan He, Ziqiang Chen, Chaowen Yang, Xiaomei Chen, Shuai Wang, You‐Cai Xiao, Fen‐Er Chen.

What is the DOI of this paper?

10.1021/acs.jmedchem.6c01649, permanently at https://doi.org/10.1021/acs.jmedchem.6c01649. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.